| Cara Schmitt, PT | |
|
2121 Ne 139th St, Vancouver, WA 98686 | |
| (360) 487-3750 | |
| (503) 413-4379 |
| Full Name | Cara Schmitt |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2121 Ne 139th St, Vancouver, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043371024 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | LL00004343 (Washington) | Primary |
| 235Z00000X | Speech-language Pathologist | 11272 (Oregon) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Cara Schmitt, PT 2121 Ne 139th St, Vancouver, WA 98686 Ph: (360) 487-3750 | Cara Schmitt, PT 2121 Ne 139th St, Vancouver, WA 98686 Ph: (360) 487-3750 |
News Archive
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular diseases, today announced that during the first quarter of 2010, through its previously established equity distribution agreement, it raised net proceeds of approximately $6.8 million through the sale of 1,075,000 shares of ARCA common stock in open market.
Boehringer Ingelheim Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration granted approval of Praxbind (idarucizumab). PRAXBIND is indicated for patients treated with Pradaxa (dabigatran etexilate mesylate), when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery/urgent procedures or in life-threatening or uncontrolled bleeding.
New insights on how subunits of the influenza virus polymerase co-evolve to ensure efficient viral RNA replication are provided by a study published October 3 in the open-access journal PLOS Pathogens by Nadia Naffakh of the Institut Pasteur, and colleagues. As the authors note, the findings could lead to novel strategies for antiviral drug development.
Scientists have manufactured a synthetic form of peptide to combat viral infections, with tests already conducted on HSV-1 as well as SARS-CoV-2.
A team led by University of Saskatchewan (USask) researcher Khan Wahid has been awarded $250,000 from the federal New Frontiers in Research Fund to create a new pill-sized capsule that uses artificial intelligence (AI)-enabled sensing to diagnose gastrointestinal cancers and bleeding earlier and more precisely than is currently possible.
› Verified 4 days ago
Mrs. Joyelle K Divall Rayan, MS CCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7825 Ne 130th Ave, Vancouver, WA 98682 Phone: 360-604-3425 | |
Mrs. Renee A Crawford, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2700 Nw 119th St # Stl, Vancouver, WA 98685 Phone: 360-313-1750 | |
Dawn Lalonde, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2301 Ne 157th St, Vancouver, WA 98686 Phone: 360-907-6357 | |
Kimberly Wilkerson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 201 Ne Park Plaza Dr, Suite 246, Vancouver, WA 98684 Phone: 360-696-1070 Fax: 360-737-0200 | |
Jenna Lynn Frink, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 611 Grand Blvd, Vancouver, WA 98661 Phone: 360-418-0419 | |
Tracy Lee Moser, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6511 Ne 18th St, Vancouver, WA 98661 Phone: 360-759-4917 Fax: 360-759-4921 | |
Mr. Francis Timothy Regan, M.S. SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3212 E Evergreen Blvd, Vancouver, WA 98661 Phone: 360-313-1988 |